| 000 | 05148nam a2200361 i 4500 | ||
|---|---|---|---|
| 003 | CSPC | ||
| 005 | 20250424162638.0 | ||
| 008 | 250414s2022 njua 001 0 eng d | ||
| 020 | _a9781119592167 | ||
| 040 |
_aCSPC _beng _erda _cDLC _dCSPC |
||
| 050 | 0 | 0 |
_aQR46 _b.G47 |
| 082 | 0 | 0 |
_223 _a616.9041 _bG412m |
| 100 | 1 |
_aGillespie, Stephen. H., _eauthor. |
|
| 245 | 1 |
_aMedical microbiology and infection at a glance / _cStephen H. Gillespie and Kathleen B. Bamford. |
|
| 250 | _aFifth edition. | ||
| 264 | 1 |
_aHoboken, New Jersey : _bWiley-Blackwell, _c2022. |
|
| 300 |
_axi, 148 pages : _b illustrations (color) ; _c28 cm. |
||
| 336 |
_2rdacontent _atext _btxt |
||
| 337 |
_2rdamedia _aunmediated _bn |
||
| 338 |
_2rdacarrier _avolume _bnc |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aMicrobial pathogens, classification and concepts -- Innate and acquired immunity -- The 'normal' flora in health and disease -- Pathogenicity and pathogenesis of infectious disease -- Making a microbiological diagnosis of infection -- Antimicrobial therapy - principles and concepts -- Antibacterial agents - pharmacology and modes of action -- Antimicrobial use and stewardship -- Emergence and detection of resistance -- Sources and transmission of infection -- Principles of infection control -- Infection in the healthcare environment -- Immunization -- Emerging infections -- High consequence infectious diseases and bioterrorism preparedness -- Staphylococcus -- Haemolytic streptococcal infections -- Other Gram-positive cocci and the alpha-haemolytic streptococci -- Streptococcus pneumoniae -- Listeria, bacillus, non-diphtheria corynebacterium -- Diphtheria, tetanus and pertussis -- Mycobacterium tuberculosis -- Non-tuberculous mycobacteria and leprosy -- Clostridium -- Non-sporing anaerobic infections -- Neisseria and Moraxella -- Small Gram-negative coccobacilli: Haemoophilus, Brucella, Francisella, Yersinia and Bartonella -- Pathogenicity of enteric Gram-negative bacteria -- Enterobacteriaceae clinical syndromes -- Vibrio, Campylobacter and Helicobacter -- Environmental pathogens: Pseudomonas, Burkholderia, Legionella and Acinetobacter -- Chlamydia, Mycoplasma and Rickettsia -- Spiral bacteria -- Virus structure and classification -- Antiviral therapy -- Herpesviruses I -- Herpesviruses II -- DNA viruses: adenovirus, parvovirus and poxvirus -- Measles, mumps and rubela -- Influenza viruses -- Parainfluenza and other respiratory viruses -- Enterovirus and viruses that infect the gastrointestinal tract -- Hepatitis virus -- Tropical, exotic or arbovirus infections -- Yeast infections -- Filamentous fungi -- Antifungal drugs and antifungal therapy -- Intestinal protozoa -- Malaria, leishmaniasis and trypanosomiasis -- Intestinal helminths -- Tissue helminths -- Congenital and perinatal infections -- HIV infection and AIDS -- Pyrexia of unknown origin and pueperal sepsis -- Sepsis -- Endocarditis, myocarditis and pericarditis -- Infections of the central nervous system -- Acute respiratory tract infections -- Chronic infections of the lung and hospital acquired pneumonia -- Urinary and genital infections -- Infections of the bones and joints -- Bacterial diarrhoeal disease -- Zoonoses -- Infections in immunocompromised patients -- Ocular infections -- Infection of the skin and soft tissue. | |
| 520 | _a"Since the publication of the fourth edition the pace of change in the world of infection has increased. We have seen a global pandemic of a novel pathogen and increasing fears about the risks of antibiotic resistance. These challenges are reflected in the scale of this revision where there has been a comprehensive update to epidemiological, diagnostic and therapeutic components throughout the book. New chapters on innate immunity, antibacterial, antiviral and antifungal therapy, non-tuberculosis mycobacteria, response to emerging infections, and chronic respiratory infections have been added. The figures have been updated to reflect new information and many new figures created. The availability of information has changed since the first edition of this book was written and the section on further reading has been expanded to point learners to sources of current guidelines and advice. This revision was completed during the COVID-19 pandemic and this event emphasised the importance of infection and infection control to every health care worker wherever they practice. Medical Microbiology and Infection at a Glance fifth edition continues to provide a comprehensive introduction to the topic of human infection and to provide learners at all stages of their clinical life a framework upon which they can build comprehensive knowledge for clinical practice" | ||
| 650 | 0 | _aMedical microbiology. | |
| 650 | 0 | _aCommunicable diseases. | |
| 650 | 0 | _aInfection. | |
| 650 | 0 | _aMicrobiological phenomena. | |
| 650 | 0 | _aCommunicable diseases. | |
| 650 | 0 | _aInfections. | |
| 700 | 1 |
_aBamford, Kathleen B., _eauthor. |
|
| 942 |
_2ddc _n0 _cBK _e23 _h616.9041 _iG412m _kNUR _m2022 |
||
| 999 |
_c29395 _d29395 |
||